Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing.
about
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingInduced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsHuman-induced pluripotent stem cell models of inherited cardiomyopathiesClinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem CellsTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicinehiPSC Modeling of Inherited CardiomyopathiesModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesProspects for In Vitro Myofilament Maturation in Stem Cell-Derived Cardiac Myocytes.Cardiotrophin-1 promotes cardiomyocyte differentiation from mouse induced pluripotent stem cells via JAK2/STAT3/Pim-1 signaling pathway.Genetic testing for inherited cardiac disease.Desmosomes in the heart: a review of clinical and mechanistic analyses.Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.Animal Models of Congenital Cardiomyopathies Associated With Mutations in Z-Line Proteins.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Disease modelling using human iPSCs.Phenotypic assays for analyses of pluripotent stem cell-derived cardiomyocytes.Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features.Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.Lysosomal membrane permeabilization is involved in oxidative stress-induced apoptotic cell death in LAMP2-deficient iPSCs-derived cerebral cortical neurons.Molecular insights into cardiomyopathies associated with desmin (DES) mutations
P2860
Q26750618-B1485681-EA76-42B9-94AB-10FF75006754Q26781825-47F876B1-7668-4AA6-8EF9-CAC5B0E5B78FQ26798131-1288EFE4-8E95-435A-8A3D-BF3D3B5A49CEQ26852052-0F30C118-92CB-4273-893E-6CA5066F81F4Q27021919-BEC6CBAA-1756-4435-BD2B-B2FDD1B4F830Q28076397-99CAA3D6-C173-40DF-937D-B4202F073DBDQ28240320-EFAF72D8-847E-4934-9D8A-8EDAE319C87AQ28255887-0464A144-F395-4DE1-A9AE-DBFC37EBB4FBQ35724421-78A1A81B-4873-43B9-8D90-5A225E3D8B18Q36460901-23339F00-6031-43B6-98E6-99FA563FA9EAQ38125385-ADAA9215-D3C6-4AB4-8C5E-95808605C7DEQ38206258-1ED27B05-D005-48AD-88E4-49114D86E32BQ38393181-F6BEC7F2-2BBF-43DD-BA6D-240802F49F4FQ38454536-5AAEFD0A-C6FF-4B4F-8C63-5E75D9FF0923Q38530607-1F47229F-133D-433E-AEB1-766D55ED3863Q38743378-451E3FAD-8085-4C44-9A37-674326DE4E75Q38786687-BC379851-A1A6-4D1C-9074-4C7346BC801EQ38832827-4A59AB0E-A32B-4B69-8F1D-633CB27A0615Q38874111-0FCA4103-EB0A-4A94-9AB6-17BA9B566B3DQ38919220-7EE37D54-8E02-4875-88CF-B4ABCD43F5F6Q39044287-E7F88168-9264-4164-8E28-C66ECDF41018Q39050993-E04D7047-F9C6-45F1-9483-C19F7214FE57Q39345477-9E450D45-184D-4EC4-8101-A101C2A8EAD5Q39384466-CC4E7973-9EA1-460E-88D9-DB1AD2F9B793Q41628207-128A7444-C685-47D7-9980-FCC0A06B4351Q41664792-F55C4B06-216C-470A-928E-A30831DEE6EFQ41683263-7834A3BA-AA72-4277-9F41-E741F6480E9BQ57171610-659238DD-8FB7-40DE-A486-FD292C2AD323
P2860
Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@ast
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@en
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@nl
type
label
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@ast
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@en
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@nl
prefLabel
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@ast
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@en
Patient-specific induced-pluri ...... ied by whole exome sequencing.
@nl
P2093
P2860
P50
P356
P1476
Patient-specific induced-pluri ...... fied by whole exome sequencing
@en
P2093
Alan Colman
Amy W Butler
Chung-Wah Siu
Jenny C Y Ho
Jinqiu Zhang
John M Nicholls
Ka-Wing Au
Kenneth W J Lay
Kwong-Man Ng
Miguel A Esteban
P2860
P304
P356
10.1093/HMG/DDS556
P577
2013-01-08T00:00:00Z